238 related articles for article (PubMed ID: 17004096)
1. Cerebral malaria in spite of peripheral parasite clearance in a patient treated with atovaquone/proguanil.
Koch S; Göbels K; Richter J; Oette M; Häussinger D
Parasitol Res; 2007 Mar; 100(4):747-8. PubMed ID: 17004096
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.
Sutherland CJ; Laundy M; Price N; Burke M; Fivelman QL; Pasvol G; Klein JL; Chiodini PL
Malar J; 2008 Nov; 7():240. PubMed ID: 19021900
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children.
Tahar R; Almelli T; Debue C; Foumane Ngane V; Djaman Allico J; Whegang Youdom S; Basco LK
J Infect Dis; 2014 Dec; 210(12):1962-71. PubMed ID: 24943722
[TBL] [Abstract][Full Text] [Related]
4. [Atovaquone-proguanil treatment failure in Plasmodium falciparum].
Contentin L; Grammatico-Guillon L; Desoubeaux G; Baron S; Thanh HD
Presse Med; 2011 Nov; 40(11):1081-3. PubMed ID: 21570798
[No Abstract] [Full Text] [Related]
5. Atovaquone-Proguanil Remains a Potential Stopgap Therapy for Multidrug-Resistant Plasmodium falciparum in Areas along the Thai-Cambodian Border.
Saunders DL; Chaorattanakawee S; Gosi P; Lanteri C; Somethy S; Kuntawunginn W; Ittiverakul M; Chann S; Gregory C; Chuor CM; Prom S; Spring MD; Lon C
Antimicrob Agents Chemother; 2015 Dec; 60(3):1896-8. PubMed ID: 26711753
[TBL] [Abstract][Full Text] [Related]
6. Atovaquone-proguanil for recrudescent Plasmodium falciparum in Vietnam.
Giao PT; De Vries PJ; Hung LQ; Binh TQ; Nam NV; Kager PA
Ann Trop Med Parasitol; 2003 Sep; 97(6):575-80. PubMed ID: 14511555
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Analysis of the Interaction between Atovaquone and Proguanil against Liver Stage Malaria Parasites.
Barata L; Houzé P; Boutbibe K; Zanghi G; Franetich JF; Mazier D; Clain J
Antimicrob Agents Chemother; 2016 Jul; 60(7):4333-5. PubMed ID: 26926628
[TBL] [Abstract][Full Text] [Related]
8. [Three newly registered drugs in the Netherlands for the treatment and chemoprophylaxis of malaria: atovaquone-proguanil, artemether-lumefantrine and artemotil].
Kager PA
Ned Tijdschr Geneeskd; 2003 Feb; 147(7):291-5. PubMed ID: 12622006
[TBL] [Abstract][Full Text] [Related]
9. Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil.
van Vugt M; Leonardi E; Phaipun L; Slight T; Thway KL; McGready R; Brockman A; Villegas L; Looareesuwan S; White NJ; Nosten F
Clin Infect Dis; 2002 Dec; 35(12):1498-504. PubMed ID: 12471569
[TBL] [Abstract][Full Text] [Related]
10. A Case of Recrudescence Plasmodium falciparum Malaria Treated with Atovaquone-Proguanil.
Kaman A; Tanır G; Akkaya B; Bayhan Gİ; Gayretli Aydın ZG; Aydın Teke T
Turkiye Parazitol Derg; 2018 Sep; 42(3):233-236. PubMed ID: 30072357
[TBL] [Abstract][Full Text] [Related]
11. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
[TBL] [Abstract][Full Text] [Related]
12. Atovaquone and proguanil hydrochloride for treatment of malaria.
Kremsner PG; Looareesuwan S; Chulay JD
J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of atovaquone-proguanil compared with mefloquine in the treatment of nonimmune patients with uncomplicated P. falciparum malaria in Japan.
Hitani A; Nakamura T; Ohtomo H; Nawa Y; Kimura M
J Infect Chemother; 2006 Oct; 12(5):277-82. PubMed ID: 17109092
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group.
Kimura M; Koga M; Kikuchi T; Miura T; Maruyama H
Parasitol Int; 2012 Sep; 61(3):466-9. PubMed ID: 22484597
[TBL] [Abstract][Full Text] [Related]
15. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
Legrand E; Demar M; Volney B; Ekala MT; Quinternet M; Bouchier C; Fandeur T; Rogier C; Carme B; Puijalon OM; Esterre P
Antimicrob Agents Chemother; 2007 Jun; 51(6):2280-1. PubMed ID: 17438062
[No Abstract] [Full Text] [Related]
16. Plasmodium falciparum malaria occurring four years after leaving an endemic area.
Vantomme B; Van Acker J; Rogge S; Ommeslag D; Donck J; Callens S
Acta Clin Belg; 2016 Apr; 71(2):111-3. PubMed ID: 26312505
[TBL] [Abstract][Full Text] [Related]
17. An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia.
Dell'Acqua R; Fabrizio C; Di Gennaro F; Lo Caputo S; Saracino A; Menegon M; L'Episcopia M; Severini C; Monno L; Castelli F; Angarano G
Malar J; 2017 Apr; 16(1):149. PubMed ID: 28410610
[TBL] [Abstract][Full Text] [Related]
18. A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy.
McGready R; Ashley EA; Moo E; Cho T; Barends M; Hutagalung R; Looareesuwan S; White NJ; Nosten F
J Infect Dis; 2005 Sep; 192(5):846-53. PubMed ID: 16088834
[TBL] [Abstract][Full Text] [Related]
19. Artemisinin-based combination therapy (ACT) versus atovaquone-proguanil: do not choose between but, rather, combine them.
Schwartz E; Lachish T
Evid Based Med; 2016 Apr; 21(2):64. PubMed ID: 26759150
[No Abstract] [Full Text] [Related]
20. [Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment].
Forestier E; Labe A; Raffenot D; Lecomte C; Rogeaux O
Med Mal Infect; 2011 Jan; 41(1):41-3. PubMed ID: 20800398
[No Abstract] [Full Text] [Related]
[Next] [New Search]
